BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17683170)

  • 1. Current management of mantle cell lymphoma.
    Weigert O; Unterhalt M; Hiddemann W; Dreyling M
    Drugs; 2007; 67(12):1689-702. PubMed ID: 17683170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mantle cell lymphoma: state-of-the-art management and future perspective.
    Weigert O; Unterhalt M; Hiddemann W; Dreyling M
    Leuk Lymphoma; 2009 Dec; 50(12):1937-50. PubMed ID: 19863180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of mantle cell lymphoma].
    Dreyling M; Unterhalt M; Weigert O; Hiddemann W
    Internist (Berl); 2007 Apr; 48(4):382-8. PubMed ID: 17308912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse aggressive lymphoma.
    Fisher RI; Miller TP; O'Connor OA
    Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment standards and emerging strategies in mantle cell lymphoma.
    Dreyling M; Hiddemann W;
    Hematology Am Soc Hematol Educ Program; 2009; ():542-51. PubMed ID: 20008239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mantle cell lymphoma: established therapeutic options and future directions.
    Lenz G; Dreyling M; Hiddemann W
    Ann Hematol; 2004 Feb; 83(2):71-7. PubMed ID: 14669040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of lymphoma.
    Abbott BL
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):30-2. PubMed ID: 16879767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
    Krishnan A; Nademanee A; Fung HC; Raubitschek AA; Molina A; Yamauchi D; Rodriguez R; Spielberger RT; Falk P; Palmer JM; Forman SJ
    J Clin Oncol; 2008 Jan; 26(1):90-5. PubMed ID: 18025438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and therapy of mantle cell lymphoma.
    Williams ME; Densmore JJ
    Curr Opin Oncol; 2005 Sep; 17(5):425-31. PubMed ID: 16093790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current regimens and novel agents for mantle cell lymphoma.
    Chen Y; Wang M; Romaguera J
    Br J Haematol; 2014 Oct; 167(1):3-18. PubMed ID: 24974852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Risk Mantle Cell Lymphoma in the Era of Novel Agents.
    Nabrinsky E; Danilov AV; Koller PB
    Curr Hematol Malig Rep; 2021 Feb; 16(1):8-18. PubMed ID: 33507515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis and outcome of stem cell transplantation for mantle cell lymphoma.
    Cheminant M; Robinson S; Ribrag V; Le Gouill S; Suarez F; Delarue R; Hermine O
    Expert Rev Hematol; 2015 Aug; 8(4):493-504. PubMed ID: 26091558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphoma: are current therapies changing the course of disease?
    Geisler C
    Curr Oncol Rep; 2009 Sep; 11(5):371-7. PubMed ID: 19679012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of mantle cell lymphoma: current approach and future directions.
    Brody J; Advani R
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):257-65. PubMed ID: 16751087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
    Lenz G; Dreyling M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mantle cell lymphoma: targeting the microenvironment.
    Drach J; Seidl S; Kaufmann H
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):477-85. PubMed ID: 16001955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.
    Ansell SM; Ristow KM; Habermann TM; Wiseman GA; Witzig TE
    J Clin Oncol; 2002 Sep; 20(18):3885-90. PubMed ID: 12228209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic advances for indolent lymphomas].
    Ogura M
    Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current treatment strategy in mantle cell lymphoma].
    Ogura M
    Nihon Rinsho; 2014 Mar; 72(3):499-511. PubMed ID: 24724411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of mantle cell lymphoma: current standards and future strategies.
    Schmidt C; Dreyling M
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):953-63, ix. PubMed ID: 18954745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.